Trial intelligence / Profile preview

Metronidazole plus levofloxacin before IVF after repeated failed IVF

IRCT20200825048515N24Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of metronidazole and levofloxacin in infertility and Unexplained infertility (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Serum beta-human chorionic gonadotropin level and IVF result. Started Feb 2021; status: completed.

02

Drugs

metronidazolelevofloxacin
03

Conditions

infertilityUnexplained infertility

Beyond the preview

Go deeper on IRCT20200825048515N24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200825048515N24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call